PTEN Protein Loss by IHC Is an Adverse Prognostic Indicator in a High Risk Surgical Cohort of Prostate Cancer Patients

被引：0
|
作者：
Lotan, T. L. [1 ]
Suteliffe, S. [1 ]
Gurel, B. [1 ]
Park, B. H. [1 ]
Humphries, E. [1 ]
Partin, A. W. [1 ]
Han, M. [1 ]
Walsh, P. C. [1 ]
De Marzo, A. M. [1 ]
机构：
[1] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
来源：
MODERN PATHOLOGY | 2010年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
909
引用
收藏
页码：205A / 205A
页数：1
相关论文
共 50 条
  • [31] Extramural vascular invasion is an adverse prognostic indicator of survival in patients with colorectal cancer
    Courtney, E. D.
    West, N. J.
    Kaur, C.
    Ho, J.
    Kalber, B.
    Hagger, R.
    Finlayson, C.
    Leicester, R. J.
    COLORECTAL DISEASE, 2009, 11 (02) : 150 - 156
  • [32] Cell cycle progression score and PTEN as prognostic factors for metastasis in intermediate and high-risk prostate cancer.
    Trock, Bruce J.
    Rajamani, Saradha
    Vidal, Igor
    Glavaris, Stephanie
    Jones, Tracy
    Han, Misop
    Partin, Alan W.
    Cohen, Todd
    Stone, Steven
    De Marzo, Angelo M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [33] Surgical treatment and/or radiotherapy in high risk prostate cancer
    Bicaklioglu, Fatih
    Acar, Cenk
    Sozen, Sinan
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2013, 12 (02): : 97 - 101
  • [34] Surgical treatment of high-risk prostate cancer
    Soares, R.
    Eden, C. G.
    MINERVA UROLOGICA E NEFROLOGICA, 2015, 67 (01) : 33 - 46
  • [35] Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients
    Szkandera, J.
    Stotz, M.
    Absenger, G.
    Stojakovic, T.
    Samonigg, H.
    Kornprat, P.
    Schaberl-Moser, R.
    AlZoughbi, W.
    Lackner, C.
    Ress, A. L.
    Seggewies, F. S.
    Gerger, A.
    Hoefler, G.
    Pichler, M.
    BRITISH JOURNAL OF CANCER, 2014, 110 (01) : 183 - 188
  • [36] An analysis of prognostic factors in patients with clinically localized high risk prostate cancer.
    Le, QT
    Ryu, JK
    Lewis, P
    Roach, M
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 293 - 293
  • [37] Prognostic significance of castrate testosterone levels for patients with intermediate and high risk prostate cancer
    Ozyigit, Gokhan
    Hurmuz, Pervin
    Yuce, Deniz
    Akyol, Fadil
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2019, 10 (08): : 283 - 292
  • [38] Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients
    J Szkandera
    M Stotz
    G Absenger
    T Stojakovic
    H Samonigg
    P Kornprat
    R Schaberl-Moser
    W AlZoughbi
    C Lackner
    A L Ress
    F S Seggewies
    A Gerger
    G Hoefler
    M Pichler
    British Journal of Cancer, 2014, 110 : 183 - 188
  • [39] Prognostic significance of PSA in the outcomes of patients with high risk localized prostate cancer.
    Khosla, Atulya Aman
    Prabhakar, Pushan
    Pon Avudaiappan, Arjun
    Jatwani, Karan
    Ahluwalia, Manmeet Singh
    Manoharan, Murugesan
    Garje, Rohan
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL) : 347 - 347
  • [40] Prognostic value of p16, PTEN, E-cadherin, and bcl-2 expression in high risk prostate cancer of Korean patients
    Kim, M. J.
    Kim, J. M.
    Sung, W. J.
    Seok, S. H.
    Kim, A. R.
    Im, W. S.
    Park, D. C.
    LABORATORY INVESTIGATION, 2008, 88 : 163A - 163A
12345